Загрузка...
Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma
SIMPLE SUMMARY: Immunotherapy-based treatment options have become standard of care in metastatic renal cell carcinoma. Despite significant improvement in overall survival with these therapies, the tumors of many patients will eventually progress. This review highlights the ongoing efforts to develop...
Сохранить в:
| Опубликовано в: : | Cancers (Basel) |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7565517/ https://ncbi.nlm.nih.gov/pubmed/32961934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092662 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|